Rephonic
Artwork for Smart Biotech Scientist

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders

David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
Biotechnology
Bioprocess Development
Biomanufacturing
Bioprocessing
Artificial Intelligence
Cell Therapy
Gene Therapy
Cell and Gene Therapy
Drug Development
Biologics Manufacturing
Continuous Manufacturing
Cell Culture
Biologics
Regulatory Compliance
Clinical Trials
Process Development
Biopharmaceutical Manufacturing
FDA
Personalized Medicine
Biotech

The go-to CMC and biomanufacturing podcast for bioprocess development scientists and CMC leaders scaling biologics into regulatory-ready therapies with less trial and error.

Practical, execution-focused, and strategic guidance on CMC development, tech transfer, scale-up, GMP readiness, CDMO partnerships, and manufacturing economics for biologics, cell and gene therapies, cultivated meat, and biom... more

PublishesDailyEpisodes299Founded3 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for Smart Biotech Scientist

Latest Episodes

The entire public record of antibody affinity data comes to about half a million measurements, and by David Younger's estimate, upwards of 75% of it is AlphaSeq data from his own company's publications. His conclusion is that no single company can cl... more

The Protein Data Bank holds about 10,000 antibody-antigen structures and grows by roughly 1,000 a year. David Younger's scaling work suggests that generalizable de novo antibody design needs hundreds of thousands to millions. At that pace, even 200,0... more

YouTube

Cardiovascular disease has long been managed by slowing its relentless progression. But Matthew O'Connor, CEO of Scientific Affairs at Cyclarity Therapeutics, is betting on an outright paradigm shift: treating atherosclerotic plaque with therapies de... more

Why does CMC development still expect every drug to be one molecule with one peak, when new therapeutics don't always fit neatly into existing regulatory or chemical categories?

Matthew O'Connor, CEO of Scientific Affairs at Cyclarity Therapeutics, ... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Matthew O'Connor
CEO of Scientific Affairs at Cyclarity Therapeutics
Cyclarity Therapeutics
Episode: 296: Neither Small Molecule nor Biologic: The Cyclodextrin Dimer CMC Challenge with Matthew O'Connor - Part 2
Christian Witz
CEO and founder of SimVantage
SimVantage
Episode: 294: Is CFD Overkill for Your Scale-Up? Why It Belongs in Every Biotech Scientist's Toolkit with Christian Witz - Part 2
John Bonham-Carter
Founder/CEO with experience building multiple biotech ventures and investor/board advisor
Stellion Biosystems (current venture mentioned)
Episode: 292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2
Sandra Núñez
CEO of Amela Biosciences
Amela Biosciences
Episode: 290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2
Sigma Mostafa
Chief Scientific and Technology Officer
KBI Biopharma
Episode: 288: Why the Cell Line Is the CMC Decision You Don't Get to Undo with Sigma Mostafa - Part 2
Nathan Lewis
Professor at the University of Georgia; glycoprotein and glycosylation expert
University of Georgia
Episode: 286: Why Your Dormant Omics Data Is Worth More Than the Data You'll Generate Next with Nathan Lewis - Part 2
Kent Rapp
Co-Founder and CEO of Biolinco
Biolinco
Episode: 284: Detecting 1 in 100,000 Cells: DNA Barcoding for Smarter Clone Selection with Kent Rapp - Part 2
Jitendra Kumar
Representative of Entos Pharmaceuticals
Entos Pharmaceuticals
Episode: 282: When Your Delivery Vehicle Contains a Membrane Protein: CMC Decisions With No Regulatory Precedent with Jitendra Kumar - Part 2
Christopher Locher
CEO and co-founder of Versatope Therapeutics
Versatope Therapeutics
Episode: 280: Why Nanovesicles Outperform Exosomes: Scalable Drug Delivery Beyond Injectable Vaccines with Christopher Locher - Part 2

Host

David Brühlmann
Host of the Smart Biotech Scientist podcast focused on bioprocess development and manufacturing leadership. Provides strategic CMC insights and interview guidance rooted in decades of bioprocess experience.

Reviews

4.9 out of 5 stars from 33 ratings
  • Good stuff !

    I am enjoying this podcast and always learn a thing or two! Thanks David!

    Apple Podcasts
    5
    Rob78_13
    United States2 years ago
  • Insightful!

    I love my weekly dose of the Smart Biotech Scientist podcast! I enjoy hearing and learning from my peers in the biopharmaceutical development field, gaining new insights and perspectives on CMC development challenges, tech, and strategies. The host is knowledgeable and engaging, bringing expert guests who share their cutting-edge strategies and real-world experiences. Whether you’re a seasoned professional or new to the field, this podcast offers practical advice and innovative solutions that c... more

    Apple Podcasts
    5
    Giulia Lambiase
    United Kingdom2 years ago
  • Great interviews, good format

    David delivers a great podcasts: I like the depth of the conversations and also that the episodes have the perfect length for my commute to work👍

    Apple Podcasts
    5
    pilldipp
    Germany3 years ago
  • Deeply Refreshing Perspective

    I am really a fan of David’s content and his approach to intriguing subjects.

    Apple Podcasts
    5
    Stem Cell Guy
    United States3 years ago
  • Fantastic content!

    Great podcast! Highly recommend that anybody working in biotech listen to this podcast. David, the host, is very knowledgeable in the bio tech space. I have enjoyed the insights from the guests.

    Apple Podcasts
    5
    MatthiasV1976
    United States3 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Guests and topics consistently receive high regard for depth, clarity, and relevance to daily challenges in biotech manufacturing.
The show is described as a must-listen for bioprocess professionals looking for actionable insights and up-to-date industry perspectives.
Listeners praise the host for domain expertise and engaging guests that share practical, real-world strategies.
Fans note the concise episode lengths and focus on tangible, scalable solutions as standout strengths.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

276: From Lab-Scale Molding to GMP: Manufacturing a Collagen Implant for the Clinic with Eva-Maria Balet - Part 2
Q: What is the most important takeaway from your conversation today?
Translating science into real impact relies on collaboration, mindset, and surrounding yourself with the right people, not just great ideas; progress comes through meaningful connections and interdisciplinary teamwork.
276: From Lab-Scale Molding to GMP: Manufacturing a Collagen Implant for the Clinic with Eva-Maria Balet - Part 2
Q: What are the skills you're building now through your executive MBA, and what would you recommend founders develop early on?
Balet describes how the MBA helped apply finance, accounting, and strategic communication to the business side of biotech, emphasizing the value of upskilling for leadership and the ability to connect science to commercial strategy.
276: From Lab-Scale Molding to GMP: Manufacturing a Collagen Implant for the Clinic with Eva-Maria Balet - Part 2
Q: What was the hardest moment so far in your company history and what did this teach you?
The hardest moment was the first inium trial pre-approval being followed by COVID shutdowns, which delayed manufacturing and surgeries; this taught the importance of adaptability, continuing development, and keeping multiple plans in motion.
296: Neither Small Molecule nor Biologic: The Cyclodextrin Dimer CMC Challenge with Matthew O'Connor - Part 2
Q: Where can people connect with you?
He invites listeners to connect via Cyclarity Therapeutics' website and LinkedIn, and to reach out for collaborations or investment conversations.
296: Neither Small Molecule nor Biologic: The Cyclodextrin Dimer CMC Challenge with Matthew O'Connor - Part 2
Q: Speaking of vision, Matthew, how do you think we'll be treating cardiovascular disease in 10 years from now?
We'll have imaging-enabled, non-invasive diagnostics combined with treatments that not only slow but reverse plaque buildup, potentially allowing full-body imaging-driven strategies and earlier intervention.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Smart Biotech Scientist

What is Smart Biotech Scientist about and what kind of topics does it cover?

A practical, execution-focused show that speaks to bioprocess development and CMC leaders scaling biologics and cell/gene therapies toward regulatory readiness. Episodes center on manufacturing scale-up, technology transfer, process development, data and automation in labs, and the economics of biopharma production, with frequent guests from major biotech suppliers, CDMOs, and innovative startups. Listeners are likely looking for actionable guidance on scale-up strategies, regulatory readiness, GMP/CMC planning, and how digital tools and AI can streamline development. A standout pattern is the access to practitioner-level insights from leaders driving real-world manufacturing improvements, often framed around building scalable platforms and... more

Where can I find podcast stats for Smart Biotech Scientist?

Rephonic provides a wide range of podcast stats for Smart Biotech Scientist. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Smart Biotech Scientist and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Smart Biotech Scientist get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Smart Biotech Scientist, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Smart Biotech Scientist?

Rephonic provides comprehensive predictive audience data for Smart Biotech Scientist, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Smart Biotech Scientist have?

To see how many followers or subscribers Smart Biotech Scientist has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Smart Biotech Scientist?

These podcasts share a similar audience with Smart Biotech Scientist:

1. The Indicator from Planet Money
2. Planet Money
3. The Daily
4. Bioprocessing Unfiltered
5. The Intelligence from The Economist

How many episodes of Smart Biotech Scientist are there?

Smart Biotech Scientist launched 3 years ago and published 299 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Smart Biotech Scientist?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Smart Biotech Scientist?

Rephonic pulls ratings and reviews for Smart Biotech Scientist from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Smart Biotech Scientist?

Rephonic provides full transcripts for episodes of Smart Biotech Scientist. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Smart Biotech Scientist?

Recent guests on Smart Biotech Scientist include:

1. Matthew O'Connor
2. Christian Witz
3. John Bonham-Carter
4. Sandra Núñez
5. Sigma Mostafa
6. Nathan Lewis
7. Kent Rapp
8. Jitendra Kumar

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days